What is EXAS's current stock price?

As of now, EXAS is trading at $64.69, with a daily change of +2.33%.

What are the risks associated with EXAS stock?

EXAS Key risk is its Moderate, .

What is EXAS next earnings date?

EXAS next earnings report is scheduled for Nov 3, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

EXAS Stock Analysis & IQ Rating | Exact Sciences

EXAS

Exact Sciences

$64.69

+$1.47 | +2.33%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 72.82

MKT CAP

$ 12.17B

52W Low

$ 38.88

VOL

$ 2.42M

P/E Ratio

N/A

AVG VOL

$ 2.13M

RSI

73.63

TREND

Uptrend

EXAS Stock IQ

Login to see Exact Sciences (EXAS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

EXAS Target Price

Login to display

Strengths

EXAS Rewards

Earnings are forecast to grow

EXAS Rewards

Upgraded on attractively valued

EXAS Rewards

Outperform the market

Chart

$57.63 (+12.25%)

$40.99 (+57.82%)

$55.66 (+16.22%)

$50.93 (+27.02%)

1year

6month

3month

1month

EXAS Risk Level

EXAS has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Moderate

LOW

HIGH

EXAS Analysts Opinion

EXAS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

EXAS Analysts Opinion

EXAS Analysts opinion is positive and also has improved from the past 3 months

EXAS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

100%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

EXAS Street Opinion

EXAS Street view is extremely bullish and have positive views on the near-term outlook

EXAS Performance Sentiment

Sentiments overview associated with EXAS events and the stock performance.

100%

0%

Positive

Negative

6 out of 6
events present

0 out of 6
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$64.64

Resistance
Price

$52.57

Current Price Range

$64.85

Show methods +

EXAS Earnings

The TTM reflects 12-month period, providing review of EXAS financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

2,940

2,759

2,500

+8.44%

Cost of Revenue

893

840

738

+10.00%

Gross Profit

2,047

1,919

1,762

+7.78%

Operating Exp

2,198

2,098

1,977

+5.44%

Operating Inc

-151

-179

-214

-

Net Interest Inc

-49

-37

-30

-

Interest Exp

-

32

24

-

Other Inc Exp

-814

-820

42

-

EPS Growth

-5.45

-5.59

-1.13

-

EXAS Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

3.45

Next Earnings Date: Nov 3, 2025

Linked to EXAS

IQ

Close Price

Change

LH

4.42

253.96

+0.58%

GH

4.12

93.02

+0.66%

EXAS Latest Analysis +

FAQ About EXAS Stock Insights

What is EXAS current stock price?

What are EXAS stock strengths?

What risks are associated with EXAS stock?

When is EXAS next earnings report?

What is EXAS market cap and volume?

What is EXAS's current Stock IQ?

Should I buy EXAS stock right now?

Is EXAS a Strong Buy right now?

What does a 'Strong Buy' rating mean for EXAS?

What does a 'Strong Sell' rating mean for EXAS?

What factors influence EXAS's Stock IQ?

Explore our EXAS Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored EXAS Stock Strategies
Effective Risk Management

FIND US ON

Receive our EXAS Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

EXAS

Exact Sciences

Current Price

$64.69

+$1.47 | +2.33%

52W High

$ 72.82

MKT CAP

$ 12.17B

52W Low

$ 38.88

VOL

$ 2.42M

P/E Ratio

N/A

AVG VOL

$ 2.13M

RSI

73.63

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

EXAS Rewards

Earnings are forecast to grow

EXAS Rewards

Upgraded on attractively valued

EXAS Rewards

Outperform the market

Linked to EXAS

Symbol

IQ

Close

Change

LH

4.42

253.96

+0.58%

GH

4.12

93.02

+0.66%

EXAS Stock IQ

Login to unlock Exact Sciences (EXAS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$57.63 (+12.25%)

$40.99 (+57.82%)

$55.66 (+16.22%)

$50.93 (+27.02%)

1year

6month

3month

1month

EXAS Analysts Opinion

EXAS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

EXAS Analysts Opinion

EXAS Analysts opinion is positive and also has improved from the past 3 months

EXAS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

100%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

EXAS Street Opinion

EXAS Street view is extremely bullish and have positive views on the near-term outlook

EXAS Risk Level

EXAS has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Moderate

LOW

HIGH

EXAS Performance Sentiment

Sentiments overview associated with EXAS events and the stock performance.

100%

0%

Positive

Negative

6 out of 6
events present

0 out of 6
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$64.64

Resistance
Price

$52.57

Current Price Range

$64.85

Show methods +

EXAS Earnings

The TTM data reflects the most recent 12-month period, providing overview of EXAS financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

2,940

2,759

2,500

+8.44%

Cost of Revenue

893

840

738

+10.00%

Gross Profit

2,047

1,919

1,762

+7.78%

Operating Exp

2,198

2,098

1,977

+5.44%

Operating Inc

-151

-179

-214

-

Net Interest Inc

-49

-37

-30

-

Interest Exp

-

32

24

-

Other Inc Exp

-814

-820

42

-

EPS Growth

-5.45

-5.59

-1.13

-

EXAS Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

3.45

Next Earnings Date: Nov 3, 2025

EXAS Latest Analysis

TEM vs. EXAS: Which Genomics Player Offers Greater Upside?. Tempus AIs soaring genomics revenues and Exact Sciences diagnostic breakthroughs spotlight two distinct routes to precision oncology growth.

Wed Oct 29, 2025

$62.74 | -0.88%

Momentum

Exact Sciences (EXAS) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release. Exact Sciences (EXAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mon Oct 27, 2025

$63.50 | -1.76%

Earnings

Potential

Is Exact Sciences (EXAS) Outperforming Other Medical Stocks This Year?. Here is how Exact Sciences (EXAS) and EssilorLuxottica Unsponsored ADR (ESLOY) have performed compared to their sector so far this year.

Thu Oct 23, 2025

$64.85 | +3.08%

Potential

BTIG Maintains Exact Sciences (EXAS) Buy Recommendation. Fintel reports that on October 22 2025 BTIG maintained coverage of Exact Sciences (NasdaqCM:EXAS) with a Buy recommendation. Analyst Price Forecast Suggests 5.56% Upside

Thu Oct 23, 2025

$64.85 | +3.08%

Rating

Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.

Mon Oct 20, 2025

$62.73 | +2.45%

Potential

Discover EXAS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of EXAS. We're here to help you make informed investment decisions today.

FIND US ON

Receive our EXAS Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

EXAS Stock trends

EXAS Stock performance

EXAS Stock analysis

EXAS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing EXAS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing EXAS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

EXAS Stock Analysis & IQ Rating | Exact Sciences

EXAS Stock IQ

EXAS Target Price

EXAS Risk Level

EXAS Analysts Opinion

EXAS Street Consensus

EXAS Performance Sentiment

Technical Price Levels

EXAS Financial Health

Explore our EXAS Stock insights

Receive our EXAS Daily Alerts

EXAS Stock IQ

EXAS Street Consensus

EXAS Risk Level

Technical Price Levels

Discover EXAS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of EXAS. We're here to help you make informed investment decisions today.

Receive our EXAS Daily Alerts

EXAS Runner Alarm